3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertensionlung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorderActive, not recruitingPhase 32026-10-06NCT04273945
SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)Aneurysm, Aortic Dissection, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dissection, Blood Vessel, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, vascular type, Hemic and Lymphatic Diseases, Skin Abnormalities, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary skin disorder, skin disorder, vascular disorder, vascular hemostatic diseaseActive, not recruitingNot stated2026-02-12NCT05976841
COLPAC (RaDiCo Cohort) (RaDiCo-COLPAC)gallbladder disease 1Active, not recruitingNot stated2026-02-12NCT05961826